Results 201 to 210 of about 68,288 (264)

Durable complete radiographic and biochemical response to olaparib in BRCA2-mutated metastatic castration-resistant prostate cancer: a long-term responder case. [PDF]

Urol Case Rep
Ito F, Kobayashi K, Hayashi G, Kamijo S, Fujita T.   +4 more
europepmc   +1 more source

BRCA2 wt Allele [PDF]

, 2020
openaire   +1 more source

The Contribution of Genetic Modifiers to Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant Carriers. [PDF]

Cancers (Basel)
Cylwik D, Dwornik R, Białkowska K.
europepmc   +1 more source

Hereditary ovarian cancer. [PDF]

Discov Oncol
Jurgiel WA, Panasiuk B, Posmyk R.
europepmc   +1 more source

BRCA2 NP_000050.2:p.S1982Rfs [PDF]

, 2020
openaire   +1 more source

Prevalence and spectrum of homologous recombination repair mutations in patients with metastatic prostate cancer from India. [PDF]

Oncologist
Baskarane H, Jain R, Divakar MK, Seth A, Nayak B, Bakhshi S, Sahoo RK, Kumar A, Sharma A, Kaushal S, Haresh KP, Hooda V, Vasudeva P, Singh PP, Agarwal R, Vasundhara S, Agarwal N, Batra A.   +17 more
europepmc   +1 more source

Unique hematological presentation of patients with biallelic inactivation of FANCD1/BRCA2. [PDF]

Blood Adv
Niewisch MR, Dierolf M, Herba AB, Thol F, Reimann C, Popp I, Holzhauer S, Behrens YL, Rohde M, Leyh J, Kühnle I, Dilloo D, Stiefel M, Schwarz-Furlan S, Baumann I, Kalb R, Kratz CP.   +16 more
europepmc   +1 more source

BRCA2 Protein Variant [PDF]

, 2020
openaire   +1 more source

Syndrome of Inappropriate Antidiuretic Hormone Secretion and Thrombotic Microangiopathy as Paraneoplastic Syndromes Complicating BRCA2-Mutated Metastatic Prostate Cancer. [PDF]

Cureus
Shapoo N, Izaguirre C, Rehman A, Mattana J, Gotlieb V.   +4 more
europepmc   +1 more source

The RRM domains of PARP14 mediate replication fork degradation in BRCA2-deficient cells. [PDF]

NAR Cancer
Hale A, Lynch KA, Dhoonmoon A, Nicolae CM, Moldovan GL.   +4 more
europepmc   +1 more source